International Oral Cancer Association
Links shared publicly online about this topic.
- 180total visits
International Oral Cancer Association
View full resource at fightoralcancer.org
Most Recently Shared on June 30, 2011 at 8:01 pm By:
Testing FacePress II WordPress Plugin ( http://knoxwebdev.com/facepress-ii ) at http://fightoralcancer.org
AACR and Landon Foundation Support the Next Generation of Researchers With INNOVATOR Awards
aacr.org — “CHICAGO — The American Association for Cancer Research and the Kirk A. and Dorothy P. Landon Foundation will present three INNOVATOR Awards at the AACR Annual Meeting 2012, held here March 31 – April 4. The Fifth Annual Landon Foundation-AACR INNOVATOR Award for Cancer Prevention Research will be presented to Guang Peng, M.D., Ph.D., at the University of Texas MD Anderson Cancer Center. The Fifth Annual Landon Foundation-AACR INNOVATOR Award for International Collaboration in Cancer ” View full resource at aacr.org
Most Recently Shared on March 27, 2012 at 8:17 pm By:
Raymond DuBois Internist, Gastroenterologist, Health Executive, Physician, and Doctor
AACR and Landon Foundation INNOVATOR Awards announced (one for Dr. Peng from MD Anderson): http://t.co/DpPKhJcN via @AddThis
Role of common genetic variants in ovarian cancer susceptibility and outcome: progress to date from the ovarian cancer association consortium (OCAC) - Bolton - 2012 - Journal of Internal Medicine - Wiley Online Library
onlinelibrary.wiley.com — “Role of common genetic variants in ovarian cancer susceptibility and outcome: progress to date from the ovarian cancer association consortium (OCAC) - Bolton - 2012 - Journal of Internal Medicine - Wiley Online Library” View full resource at onlinelibrary.wiley.com
Most Recently Shared on March 26, 2012 at 7:00 am By:
Role of common genetic variants in ovarian cancer susceptibility and outcome: progress to date from the ovarian ... http://t.co/4RW9Ef1d
Maura L. Gillison, M.D., Ph.D., Receives AACR’s Richard and Hinda Rosenthal Memorial Award | Oral Cancer News
oralcancernews.org — “Maura L. Gillison, M.D., Ph.D., Receives AACR’s Richard and Hinda Rosenthal Memorial Award | Oral Cancer News” View full resource at oralcancernews.org
Most Recently Shared on March 23, 2012 at 12:31 pm By:
Freshmedx Study Published in the Journal of Thoracic Oncology, the Official Journal of the International Association for the Study of Lung Cancer - Yahoo! Finance
finance.yahoo.com — “From Yahoo! Finance: Freshmedx today announced that its ground-breaking study on the use of computed bioconductance technology in detecting lung cancer will be published in the April edition of the Journal of Thoracic Oncology.” View full resource at finance.yahoo.com
Most Recently Shared on March 21, 2012 at 4:39 pm By:
Freshmedx Study Published in the Journal of Thoracic Oncology, the Official Journal of the International Associa... http://t.co/GO9W8pZd
Vemurafenib Extends Survival To 16 Months For Some Patients With Metastatic Melanoma
medicalnewstoday.com — “An international team of researchers from the United States and Australia, including researchers at Moffitt Cancer Center in Tampa, Fla., have found that the oral BRAF inhibitor vemurafenib (PLX40” View full resource at medicalnewstoday.com
Most Recently Shared on March 20, 2012 at 7:05 am By:
Vemurafenib Extends Survival To 16 Months For Some Patients With Metastatic Melanoma http://t.co/4ADvhzXF #skincancer #melanoma
Oral BRAF inhibitor can extend survival to 16 months for patients with MM
news-medical.net — “An international team of researchers from the United States and Australia, including researchers at Moffitt Cancer Center in Tampa, Fla., have found that the oral BRAF inhibitor vemurafenib (PLX4032) when tested in a phase II clinical trial offered a high rate of response in patients with previously treated metastatic melanoma and who had the BRAF mutation.” View full resource at news-medical.net
Most Recently Shared on March 17, 2012 at 9:26 am By:
Oral BRAF inhibitor can extend survival to 16 months for patients with MM: An international team of researchers ... http://t.co/tM2N1Vwa
Response Rate High for Some Patients with Metastatic Melanoma Treated with Vemurafenib
newswise.com — “An international team of researchers from the United States and Australia, including researchers at Moffitt Cancer Center, have found that the oral BRAF inhibitor vemurafenib (PLX4032) when tested in a phase II clinical trial offered a high rate of response in patients with previously treated metastatic melanoma and who had the BRAF mutation. More than 50 percent of the patients in the trial had positive, prolonged responses and a median survival of almost 16 months.” View full resource at newswise.com
Most Recently Shared on March 16, 2012 at 4:47 pm By:
#health news: Response Rate High for Some Patients with Metastatic Melanoma Treated with Vemurafenib http://t.co/NOOLgphV
Response Rate High for Some Patients with Metastatic Melanoma Treated with Vemurafenib
newswise.com — “An international team of researchers from the United States and Australia, including researchers at Moffitt Cancer Center, have found that the oral BRAF inhibitor vemurafenib (PLX4032) when tested in a phase II clinical trial offered a high rate of response in patients with previously treated metastatic melanoma and who had the BRAF mutation. More than 50 percent of the patients in the trial had positive, prolonged responses and a median survival of almost 16 months.” View full resource at newswise.com
Most Recently Shared on March 16, 2012 at 4:42 pm By:
newswise Health Communicator and Health News
Response Rate High for Some Patients with Metastatic Melanoma Treated with Vemurafenib http://t.co/J4PYO8lL
Panel of 10 serum protein biomarkers could help in lung cancer diagnosis
news-medical.net — “A panel of serum biomarkers could help predict the level of lung cancer risk in high-risk patients, offering doctors an option before proceeding with a biopsy. Research presented in the April 2012 issue of the International Association for the Study of Lung Cancer's (IASLC) Journal of Thoracic Oncology shows that a panel of 10 serum protein biomarkers could help in the lung cancer diagnosis.” View full resource at news-medical.net
Most Recently Shared on March 16, 2012 at 9:29 am By:
News-Medical.Net Oncology and Health News
Oncology News: Panel of 10 serum protein biomarkers could help in lung cancer diagnosis: A panel of serum biomar... http://t.co/cGjB3rQC
CYFRA reliable marker for response to chemotherapy for NSCLC
news-medical.net — “Researchers found that CYFRA and change in levels of CYFRA were found to be reliable markers for response to chemotherapy for non-small cell lung cancer (NSCLC) in a study of 88 patients. Research presented in the April 2012 issue of the International Association for the Study of Lung Cancer's (IASLC) Journal of Thoracic Oncology shows that this marker can be used to determine whether or not a patient should continue a particular chemotherapy regimen.” View full resource at news-medical.net
Most Recently Shared on March 16, 2012 at 8:40 am By:
CYFRA reliable marker for response to chemotherapy for NSCLC: Researchers found that CYFRA and change in levels ... http://t.co/fOnqyhle
CYFRA21-1 might be predictive marker in advanced NSCLC
eurekalert.org — “Researchers found that CYFRA and change in levels of CYFRA were found to be reliable markers for response to chemotherapy for non-small cell lung cancer in a study of 88 patients. Research presented in the April 2012 issue of the International Association for the Study of Lung Cancer's Journal of Thoracic Oncology shows that this marker can be used to determine whether or not a patient should continue a particular chemotherapy regimen.” View full resource at eurekalert.org
Most Recently Shared on March 16, 2012 at 6:58 am By:
CYFRA21-1 might be predictive marker in advanced NSCLC: (International Association for the Study of Lung Cancer)... http://t.co/dhAPov5G
Panel of serum biomarkers may reduce number of lung biopsies needed
eurekalert.org — “A panel of serum biomarkers could help predict the level of lung cancer risk in high-risk patients, offering doctors an option before proceeding with a biopsy. Research presented in the April 2012 issue of the International Association for the Study of Lung Cancer's Journal of Thoracic Oncology shows that a panel of 10 serum protein biomarkers could help in the lung cancer diagnosis.” View full resource at eurekalert.org
Most Recently Shared on March 15, 2012 at 6:54 pm By:
Panel of serum biomarkers may reduce number of lung biopsies needed: ( International Association for the Study o... http://t.co/QRWxcsn8
CYFRA21-1 might be predictive marker in advanced NSCLC
medicalxpress.com — “Researchers found that CYFRA and change in levels of CYFRA were found to be reliable markers for response to chemotherapy for non-small cell lung cancer (NSCLC) in a study of 88 patients. Research presented in the April 2012 issue of the International Association for the Study of Lung Cancer's (IASLC) ...” View full resource at medicalxpress.com
Most Recently Shared on March 15, 2012 at 4:20 pm By:
PhysOrg Health News Health News
CYFRA21-1 might be predictive marker in advanced NSCLC http://t.co/IxOFuUXu
Panel of serum biomarkers may reduce number of lung biopsies needed
medicalxpress.com — “A panel of serum biomarkers could help predict the level of lung cancer risk in high-risk patients, offering doctors an option before proceeding with a biopsy. Research presented in the April 2012 issue of the International Association for the Study of Lung Cancer's (IASLC) Journal of Thoracic Oncology ...” View full resource at medicalxpress.com
Most Recently Shared on March 15, 2012 at 3:48 pm By:
PhysOrg Health News Health News
Panel of serum biomarkers may reduce number of lung biopsies needed http://t.co/28Ug1Xbr
Red Meat Consumption Linked to Increased Risk of Total, Cardiovascular, and Cancer Mortality | Oral Cancer News
oralcancernews.org — “Red Meat Consumption Linked to Increased Risk of Total, Cardiovascular, and Cancer Mortality | Oral Cancer News” View full resource at oralcancernews.org
Most Recently Shared on March 15, 2012 at 1:09 pm By:
Advertisement
